close

News Center

Latest News

Center News & Funding, Research

“It feels good to represent the Hispanic community”: VCU student receives AACR Minority Scholar in Cancer Research Award

Apr 18, 2023

Matthew Fernandez, B.S., attends a poster session at the 2023 AACR annual conference

The American Association for Cancer Research (AACR) has named Matthew Fernandez, B.S., a Ph.D. student in the VCU School of Pharmacy, as a recipient of the 2023 AACR Minority Scholar in Cancer Research Award.

Fernandez is co-mentored by Douglas H. Sweet, Ph.D., chair of Pharmaceutics and E. Claiborne Robins Distinguished Professor at the VCU School of Pharmacy; and Sandro R.P. da Rocha, Ph.D., professor of Pharmaceutics and director for Pharmaceutical Engineering at the School of Pharmacy and a member of VCU Massey Cancer Center’s Developmental Therapeutics research program.

“We are delighted and very proud that he is being recognized by AACR with this prestigious Minority Scholar in Cancer Research Award,” said da Rocha. “This award not only validates his work, but it also helps him understand that he has the environment and all of the support to continue to aim high and be the best he can be.”

Fernandez presented research in the area of nanomedicine at the 2023 AACR Annual Meeting.

Matthew Fernandez, B.S., a Ph.D. student in the VCU School of Pharmacy, presents a poster at the 2023 AACR annual conference Matthew Fernandez, B.S., presents his research at the 2023 AACR Annual Meeting.

“My research is focused on improving chemotherapy efficacy for triple-negative breast cancer with macrophage-targeted immunotherapy,” Fernandez explained. “Our goal is to develop a combination therapy strategy that enhances the standard of care by reprogramming the breast tumor to a pro-inflammatory phenotype.”

According to the AACR, the purpose of the Minority Scholar in Cancer Research Award program is to increase the scientific knowledge base of minority scientists and to encourage them to pursue careers in cancer research.

“This award means a lot to me because it shows that my lab is doing good work and making strides towards improving patient outcomes for those diagnosed with triple-negative breast cancer,” said Fernandez. “It feels good to represent the Hispanic community.”

Added da Rocha, “Matthew is only in his first year of his Ph.D. in pharmaceutical sciences and clearly has a brilliant few years ahead of him.”

Fernandez joined more than a dozen VCU Massey Cancer Center researchers for the 2023 AACR Annual Meeting, held April 14-19 at the Orange County Convention Center in Orlando, Fla.

Written by: Amy Lacey

Related News

Center News & Funding, Research, Prevention & Control, Clinical, Technology

Breast imaging expert explains how new FDA mammogram rules help patients make informed decisions about their care


Center News & Funding, Community Engagement & Health Equity, Massey 50

Massey hosts congresswoman, highlights efforts to reduce cancer burden for all Virginians

Get access to new, innovative care

Get access to new, innovative care

Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.

Search clinical trials
Find a provider

Find a provider

Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.

Find a provider